Copyright
©The Author(s) 2022.
World J Diabetes. Dec 15, 2022; 13(12): 1049-1065
Published online Dec 15, 2022. doi: 10.4239/wjd.v13.i12.1049
Published online Dec 15, 2022. doi: 10.4239/wjd.v13.i12.1049
Table 1 Wagner classification system
Grade | Ulcer depth |
0 | Pre-ulcerative area without open lesion |
1 | Superficial ulcer (partial/full thickness) |
2 | Ulcer creep to tendon, capsule, bone |
3 | Stage 2 with abscess, osteomyelitis, or joint sepsis |
4 | Localized gangrene |
5 | Global foot gangrene |
Table 2 University of Texas classification system[21]
Grade 0 | Grade 1 | Grade 2 | Grade 3 | |
Pre- or post- ulcerative site | Superficial wound not involving tendon, capsule, or bone | Wound penetrating to tendon or capsule | Ulcer penetrating to bone of joint | |
Lesions without infection or ischemia | ||||
Infected/non-ischemic lesions | ||||
Ischemic noninfected lesions | ||||
Ischemic infected lesions |
Table 3 Size (area, depth), sepsis, arteriopathy, denervation system
Grade | Size | ||||
Area | Depth | Sepsis | Arteriopathy | Denervation | |
0 | Skin intact | Skin intact | None | Pedal pulses present | Pin pricks intact |
1 | < 1 cm2 | Superficial (skin and subcutaneous tissue) | Surface | Pedal pulses reduced or one missing | Pin pricks reduced |
2 | 1-3 cm2 | Tendon, periosteum, joint capsule | Cellulitis | Absence of both pedal pulses | Pin pricks absent |
3 | > 3 cm2 | Bone or joint space | Osteomyelitis | Gangrene | Charcot |
Table 4 Site, ischemia, neuropathy, bacterial infection, area, depth system[13]
Category | Definition | Score |
Site | Forefoot | 0 |
Midfoot and hindfoot | 1 | |
Ischemia | Pedal blood flow intact: At least one palpable pulse | 0 |
Clinical evidence of reduced pedal flow | 1 | |
Neuropathy | Protective sensation intact | 0 |
Protective sensation lost | 1 | |
Bacterial infection | None | 0 |
Present | 1 | |
Area | Ulcer < 1 cm2 | 0 |
Ulcer ≥ 1 cm2 | 1 | |
Depth | Ulcer confined to skin and subcutaneous tissue | 0 |
Ulcer reaching muscle, tendon or deeper | 1 | |
Total possible score | 6 |
Table 5 Wound, Ischemia, and foot Infection system
Grade | Wound | Ischemia | Foot infection system | ||
Clinical features | ABI (mmHg) | ASP (mmHg) | Toe pressure, TcPO2 (mmHg) | Clinical manifestations | |
0 | No ulcer no gangrene | ≥ 0.80 | > 100 | ≥ 60 | No symptoms or signs of infection. Infection present, as defined by the presence of at least two of the following items: (1) Local swelling or induration; (2) Erythema 0.5 cm-2 cm around the ulcer; (3) Local tenderness or pain; (4) Local warmth; and (5) Purulent discharge (thick, opaque to white, or sanguineous secretion) |
1 | Small, shallow ulcer(s) on the distal leg or foot; no exposed bone, unless limited to the distal phalanx | 0.6-0.79 | 70-100 | 40-59 | Local infection involving only the skin and the subcutaneous tissue exclude other causes of an inflammatory response of the skin (e.g., trauma, gout, acute Charcot neuro-osteoarthropathy, fracture, thrombosis, and venous stasis) |
2 | Deeper ulcer with exposed bone, joint, or tendon generally not involving the heel; shallow heel ulcer without calcaneal involvement, gangrenous changes limited to digits | 0.4-0.59 | 50-70 | 30-39 | Local infection with erythema > 2 cm, or involving structures deeper than skin and subcutaneous tissues (e.g., abscess, osteomyelitis, septic arthritis, and fasciitis), and no systemic inflammatory response signs |
3 | Extensive, deep ulcers involving forefoot and/or midfoot; deep, full-thickness heel ulcers with or without calcaneal involvement, extensive gangrene involving the forefoot and/or midfoot; full-thickness heel necrosis with calcaneal involvement | ≥ 0.39 | < 50 | < 30 | Local infection with signs of SIRS, as manifested by two or more of the following: (1) Temperature > 38 °C or < 36 °C; (2) Heart rate > 90 beats/min; (3) Respiratory rate > 20 breaths/min or PaCO2 < 32 mmHg; and (4) White blood cell count > 12000 or < 4000 cu/mm or 10% immature bands |
- Citation: Wang X, Yuan CX, Xu B, Yu Z. Diabetic foot ulcers: Classification, risk factors and management. World J Diabetes 2022; 13(12): 1049-1065
- URL: https://www.wjgnet.com/1948-9358/full/v13/i12/1049.htm
- DOI: https://dx.doi.org/10.4239/wjd.v13.i12.1049